Targeted research Small biotechnology research services firm with 11-50 employees and annual revenue in the multi-million range presents a scalable target for government and public-sector health data projects, offering upsell opportunities in data management, analytics, and biomedical information resources.

Data products Strong focus on building high-profile information resources and data accessibility aligns with needs from academic, clinical, and government clients for reliable health data, creating cross-sell opportunities for data platforms, dashboards, and AI-assisted research tools.

Tech stack fit Existing stack including SAP, .NET, C++, OpenAI, Google Analytics and Atlassian tools suggests capacity for enterprise-grade integrations, automation, and AI-enabled data processing services to expand client offerings and improve research workflows.

Public sector traction Three decades of collaboration with public-sector clients signals credibility and potential for expanded contracts, renewals, and managed services focusing on data accessibility, compliance, and mission-driven research support.

Growth-ready services Modest headcount yet robust revenue indicates opportunity to upsell consulting, managed services, and scalable data solutions to mid-market and large enterprise players in biotech, pharma, and healthcare research.